229 related articles for article (PubMed ID: 1969326)
1. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas.
Tateishi K; Shima K; Funakoshi A; Yasunami Y; Iwamoto N; Matsuoka Y
Diabetes Res Clin Pract; 1994 Aug; 25(1):43-9. PubMed ID: 7835211
[TBL] [Abstract][Full Text] [Related]
4. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
5. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
7. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
8. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
9. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
10. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro.
Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL
Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861
[TBL] [Abstract][Full Text] [Related]
11. Glicentin precedes glucagon in the developing human pancreas.
Stefan Y; Ravazzola M; Grasso S; Perrelet A; Orci L
Endocrinology; 1982 Jun; 110(6):2189-91. PubMed ID: 6122563
[TBL] [Abstract][Full Text] [Related]
12. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
Bani D; Bani Sacchi T; Biliotti G
Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
Drucker DJ; Lee YC; Asa SL; Brubaker PL
Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
[TBL] [Abstract][Full Text] [Related]
14. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
15. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic and intestinal processing of proglucagon in man.
Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
[TBL] [Abstract][Full Text] [Related]
17. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
Brubaker PL; Lee YC; Drucker DJ
J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
[TBL] [Abstract][Full Text] [Related]
18. A case of multiple endocrine neoplasia (MEN) type 1; the immunohistochemical and ultrastructural studies of its tumors and the analysis of hormones in tumor extracts.
Ishii H; Miyazaki K; Funakoshi A; Nawata H; Konomi K; Jimi A
Endocrinol Jpn; 1989 Feb; 36(1):37-45. PubMed ID: 2567230
[TBL] [Abstract][Full Text] [Related]
19. Proglucagon processing in islet and intestinal cell lines.
Tucker JD; Dhanvantari S; Brubaker PL
Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
[TBL] [Abstract][Full Text] [Related]
20. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
Rouillé Y; Kantengwa S; Irminger JC; Halban PA
J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
